Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Title Grant Type Focus Area Country Application Due Date Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)Release Date:Education Oncology USA BOOST - Multiple Myeloma An Oncology Boosting ProgramRelease Date:Quality Improvement Oncology Netherlands PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscapeRelease Date:Education Oncology All Education in the Era of Emerging Hemophilia TherapyRelease Date:Partner: National Bleeding Disorders FoundationEducation Rare Disease Guam, Puerto Rico, USA Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUCRelease Date:Education Oncology USA USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the FutureRelease Date:Education Hospital USA COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and TaiwanRelease Date:Education Vaccines All Menopause Hormone Therapy: Evidence-Based Recommendations and PracticesRelease Date:Education Internal Medicine USA Global Call for Collaborators – Pfizer Migraine ResearchRelease Date:Research Internal Medicine All Improving care in headache medicine and the management of migraineRelease Date:Quality Improvement Internal Medicine Israel The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)Release Date:Research Oncology China Elevating IBD Management Standards Through Targeted EducationRelease Date:Education Inflammation & Immunology Turkey